SANGAMO THERAPEUTICS, INC - Common Stock (SGMO)

CUSIP: 800677106

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Common Stock
Shares outstanding
294,683,714
Total 13F shares
112,297,853
Share change
+8,100,087
Total reported value
$197,560,841
Put/Call ratio
39%
Price per share
$1.76
Number of holders
178
Value change
+$11,997,591
Number of buys
95
Number of sells
58

Quarterly Holders Quick Answers

What is CUSIP 800677106?
CUSIP 800677106 identifies SGMO - SANGAMO THERAPEUTICS, INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q1 2023

As of 31 Mar 2023, SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) was held by 178 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 112,297,853 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, WASATCH ADVISORS LP, STATE STREET CORP, Rokos Capital Management LLP, CREDIT SUISSE AG/, DIMENSIONAL FUND ADVISORS LP, CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 178 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.